Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the appointment of Dustin K. Finer as chief people officer (CPO) at Covetrus, reporting to president and chief executive officer, Benjamin Shaw. In his role, Finer will lead all aspects of global human resources and, in strong partnership with Shaw, will serve as the principal strategic advisor on human capital initiatives at Covetrus.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190923005065/en/
Covetrus, a global leader in animal-health technology and services announced the appointment of Dustin K. Finer as chief people officer at Covetrus. In his role, Finer will lead all aspects of global human resources and will serve as the principal strategic advisor on human capital initiatives. (Photo: Business Wire)
“Aligning our people strategy and business strategy has been our top priority since the formation of Covetrus, as we seek to transform our global operations and unlock significant value for all of our stakeholders,” said Shaw. “Dustin has extensive experience leading internal functions for global, publicly-traded companies, and his expertise and leadership will be a significant asset as we work to strengthen and grow our team and capabilities globally.”
Finer joins Covetrus from TiVo, the entertainment technology company, where he served for more than six years—first as executive vice president of Human Resources at TiVo’s predecessor company Rovi and, most recently, as chief administrative and internal operations officer. During his tenure at TiVo, Finer successfully led diligence efforts through the company’s transformation following an acquisition by Rovi and oversaw integration initiatives across all groups. Prior to his time at TiVo and Rovi, Finer was promoted to chief of operations and executive vice president for MySpace, after first serving as chief people officer for the social networking company.
“It is an incredibly exciting time to join Covetrus,” said Finer. “Our platform and global footprint present seemingly endless potential as we look to deliver innovation and solutions that further connect our customers to their clients. I look forward to being a champion for the people and culture that power Covetrus as we realize that potential and work to advance the world of veterinary medicine.”
Finer received a Bachelor of Arts from the University of California at San Diego and a Juris Doctorate from the McGeorge School of Law at the University of the Pacific. He will be based at Covetrus’ corporate headquarters in Portland, Maine.
Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners to drive improved health and financial outcomes. We’re bringing together products, services, and technology into a single platform that connects our customers to the solutions and insights they need to work best. Our passion for the well-being of animals and those who care for them drives us to advance the world of veterinary medicine. Covetrus is headquartered in Portland, Maine, with more than 5,500 employees, serving over 100,000 customers around the globe. Learn more at covetrus.com.
This press release contains certain statements that are forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and that involve risks and uncertainties, including statements about our, plans, objectives, expectations, and intentions. Such statements are subject to numerous risks and uncertainties. Factors that could adversely affect our business and prospects are set forth in our public filings with the SEC. Our forward-looking statements are based on current beliefs and expectations of our management team and, except as required by law, we undertake no obligations to make any revisions to the forward-looking statements contained in this release or to update them to reflect events or circumstances occurring after the date of this release, whether as a result of new information, future developments or otherwise. Investors are cautioned not to place undue reliance on these forward-looking statements.